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Abstract
Background: Anemia due to iron deficiency is recognized as one of the major nutritional deficiencies in women and
children in developing countries. Daily iron supplementation for pregnant women is recommended in many countries
although there are few reports of these programs working efficiently or effectively. Weekly iron-folic acid
supplementation (WIFS) and regular deworming treatment is recommended for non-pregnant women living in areas with
high rates of anemia. Following a baseline survey to assess the prevalence of anemia, iron deficiency and soil transmitted
helminth infections, we implemented a program to make WIFS and regular deworming treatment freely and universally
available for all women of reproductive age in two districts of a province in northern Vietnam over a 12 month period.
The impact of the program at the population level was assessed in terms of: i) change in mean hemoglobin and iron status
indicators, and ii) change in the prevalence of anemia, iron deficiency and hookworm infections.
Method: Distribution of WIFS and deworming were integrated with routine health services and made available to 52,000
women. Demographic data and blood and stool samples were collected in baseline, and three and 12-month post-
implementation surveys using a population-based, stratified multi-stage cluster sampling design.
Results: The mean Hb increased by 9.6 g/L (95% CI, 5.7, 13.5, p < 0.001) during the study period. Anemia (Hb<120 g/
L) was present in 131/349 (37.5%, 95% CI 31.3, 44.8) subjects at baseline, and in 70/363 (19.3%, 95% CI 14.0, 24.6) after
twelve months. Iron deficiency reduced from 75/329 (22.8%, 95% CI 16.9, 28.6) to 33/353 (9.3%, 95% CI 5.7, 13.0) by
the 12-mnth survey, and hookworm infection from 279/366 (76.2%,, 95% CI 68.6, 83.8) to 66/287 (23.0%, 95% CI 17.5,
28.5) over the same period.
Conclusion: A free, universal WIFS program with regular deworming was associated with reduced prevalence and
severity of anemia, iron deficiency and hookworm infection when made available to Vietnamese women over a 12-month
period.
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Background
Anemia affects more than 1.5 billion people world-wide.
Women are at particular risk, with 45.7% of non-pregnant
women of reproductive age (WRA) in South-East Asia and
47.5% in Africa reported as anemic [1]. Anemia and the
primary cause, iron deficiency, lead to reduced physical
capacity, with consequences for both social and economic
development [2]. Women who become pregnant while
anemic due to insufficient iron stores are at higher risk of
preterm delivery [3]. Maternal anemia is also linked with
an increased risk of maternal death, impaired fetal
growth, low birth weight and increased neonatal mortal-
ity [4-7]. Maternal iron deficiency anemia has been shown
to be a predictor of iron deficiency in infants [8], which in
turn is a risk factor for adverse physical and cognitive
development in childhood [9,10] and has implications
for both maternal and infant mental health [11,12]. Low
intake and poor absorption of dietary iron, and blood loss
from menstruation and concurrent parasitic infections are
major contributors to anemia and iron deficiency in
women in less developed countries [7].
Food-based and supplementation strategies to improve
iron status are recommended for populations at risk of
anemia and iron deficiency [7]. Preventative weekly iron-
folic acid supplementation (WIFS) for WRA is effective in
improving iron stores [13-17] and has been advocated for
widespread use in non-pregnant women in areas with
high rates of maternal anemia [7]. This approach is sup-
ported by evidence that women with robust iron stores at
the time of conception are less likely to develop iron defi-
ciency anemia during pregnancy [18]. The current chal-
lenge is to develop implementation strategies and
programmatic experience that can sustain universal long-
term WIFS programs in resource-poor settings [19]. Viet-
nam initiated a daily iron supplementation program for
pregnant women in 1993 [20]. Despite this, a survey
undertaken in the central highlands of Vietnam in 2001
found that 62% of pregnant and 54% of non-pregnant
women were anemic [21] following a trend in many
countries that recommend similar regimens. We have pre-
viously reported 37.5% prevalence of anemia in non-
pregnant women in northern Vietnam [22].
Following a baseline survey in November 2005 [22] we
initiated a program that integrated distribution of univer-
sal WIFS and deworming into the existing health service
structure in two districts of the northern mountainous
province of Yen Bai, Vietnam, between May 2006 and
April 2007. The program has subsequently been expanded
to all districts of Yen Bai province. The broad aims were to
identify the burden of anemia, iron deficiency, and soil
transmitted helminth infections in non-pregnant WRA
(reported in Pasricha et al 2008), and to investigate the
impact of the WIFS/deworming intervention on hemo-
globin (Hb), iron status indicators and hookworm preva-
lence. In this paper we report the impact of 12 months
implementation of the WIFS/deworming intervention
and report the results of a compliance monitoring survey
conducted after three months of the intervention.
Methods
Study location and population
Yen Bai province, one of 64 provinces and cities in Viet-
nam, is a mountainous region with a largely rural econ-
omy, widespread poverty and diverse ethnic groups. Two
districts, Yen Binh and Tran Yen, were chosen for the
study. At the time each district had a total population of
approximately 26,000 WRA. Women of reproductive age
were defined in this setting as aged between 15 and 45
years and all were eligible for the intervention.
Intervention
Before the intervention, two staff of each district Depart-
ment of Preventive Medicine, two nurses from each com-
mune health station and all village health workers in the
two districts (a total of 680 health personnel) were trained
about the causes, health risks, treatment and prevention
of anemia and hookworm infection and received promo-
tional and educational materials for the women. Com-
mencing May 2006, weekly supplementation and 4
monthly deworming was implemented by active distribu-
tion through the existing health structure. Iron/folic acid
and albendazole tablets were distributed from the provin-
cial implementing agency, the Yen Bai Malaria Control
Program office, through the district Preventive Medicine
centres, to the Commune Health Stations (for albenda-
zole treatment) and on to the Village Health Workers for
distribution of the iron/folic acid tablets to the women on
a monthly basis. In addition, health workers distributed
simple educational materials. All WRA were encouraged
to collect packs of four ferrous sulphate/folic acid tablets
(60 mg/0.4 mg, UNICEF, Copenhagen) from their village
health worker each month. Albendazole (400 mg,
UNICEF, Copenhagen) was administered as observed
treatment on locally designated days either at the com-
mune health station or supervised in the village by a com-
mune health worker.
Sampling
A stratified multi-stage cluster sampling design was used
for the baseline survey, which was conducted in Novem-
ber 2005. Primary sampling units (villages) were chosen
using a 'probability proportional to size' random sam-
pling method separately within each district, with half the
target sample of villages taken from each district. Second-
ary sampling units (individual women) were selected ran-
domly from each village using provincial lists. Sample size
was calculated on an expected hemoglobin range of 90 g/
L to 140 g/L with a population standard deviation of 10 g/
L. Allowing for the clustered nature of the surveys a sam-
ple size of 250 was estimated to be sufficient to detect a 3BMC Public Health 2009, 9:261 http://www.biomedcentral.com/1471-2458/9/261
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g/L change in the mean hemoglobin. Allowing for refusals
to participate and potentially inaccessible villages, 34 vil-
lages were selected and 12 women from each village ran-
domly selected, a total of 408 women.
Post-implementation surveys were conducted after three
and 12 months of intervention using the same sampling
design for choosing participants. We used a cross sectional
survey approach for participant selection at each time
point in order to examine the population effect of the
intervention in the target districts.
Samples and testing
All surveys were conducted by the same teams and
included trained phlebotomists, stool preparation and
analysis technicians, a demographic recorder and a super-
visor. Sample collection and laboratory analysis has been
previously reported [22] and was the same in each of the
surveys. Briefly, Hb was assessed at the field site using a
HemoCue 201+ (HemoCue AB, Angelholm, Sweden). A 3
mL sample of venous blood was also collected using a
closed collection system into tubes containing fast clot-
ting agent. Serum ferritin was measured using a sandwich
immunoenzymatic assay (IEA; Beckman Coulter Access
Reagents, Fullerton, CA). Soluble transferrin receptor was
evaluated using enzyme-linked immunoassay (ELISA; IT;
Orion Diagnostica, Espoo, Finland). The ratio of transfer-
rin receptor to log (base 10) serum ferritin (TfR-F index)
was calculated from these results. Anemia was defined as
a hemoglobin concentration of <120 g/L and iron defi-
ciency as serum ferritin of < 15 μg/L, except where other-
wise stated, in concordance with WHO recommendations
for women of reproductive age [7]. Transferrin receptor
levels of 2.3 mg/L or above were considered abnormal,
based on the manufacturer's reference interval (0.8–2.3
mg/L). The TfR-F index implies depletion of iron stores
once the ratio exceeds 1.8 [23].
Faecal samples were examined microscopically for soil
transmitted helminth eggs at the field site using standard
Kato-Katz methodology [24]. Classification of hookworm
infection was based on WHO guidelines of 0 eggs per
gram (epg) as no infection, >0 and <2000 epg as mild
infection and >2000 as moderate or severe infection. Soil
transmitted helminth (STH) infection was categorized as
positive if eggs of hookworm (Ancylostoma duodenale and
Necator americanus),  Ascaris lumbricoides or  Trichuris
trichiura were detected in the stool sample.
Compliance monitoring
In July 2006, just prior to the 3-month post-implementa-
tion survey, the Research and Training Centre for Com-
munity Development (RTCCD), an independent
Vietnamese non-Government Organization, monitored
compliance in the two districts. Sampling was as
described for the surveys above. Monitoring was con-
ducted as one-to-one interviews with women and
included questions about their understanding of anemia,
iron deficiency and helminthiasis, the availability of the
intervention and their recall of accessing the deworming
treatment and taking the weekly iron tablets during the
previous 10 weeks.
Data entry and checking
Hb and helminth egg counts were entered into an Excel
(Microsoft Office 2003) spreadsheet at the field site. Team
supervisors crosschecked entries each day.
Statistical analysis
The study sample was defined as randomly selected
groups at baseline and three and twelve months post-
implementation. Hb values were approximately normally
distributed. Serum ferritin and soluble transferrin receptor
values were right-skewed and so log-transformed for anal-
ysis. For certain multi-level ordered categorical variables
(e.g. education level, place of work), some categories were
collapsed to identify relevant differences. Robust confi-
dence intervals were derived by clustering for village, the
primary sampling unit.
Linear regression analysis was used for continuous varia-
bles while binary variables were analysed by logistic
regression. For continuous variables the differences in
means between time points were calculated in absolute
values for Hb, and for the log transformed variables
(serum ferritin, soluble transferrin receptor and the TfR/F-
Index) as the ratio of the geometric means between post-
implementation and baseline surveys. Binary prevalence
variables were analysed by proportion estimation
adjusted for robust SEs with clusters as villages. Change
over time was analysed as the risk ratio between post-
implementation and baseline. Statistical analysis was per-
formed using Stata vs. 10 (StataCorp, 2005, College Sta-
tion, Texas).
Ethics
Extensive consultation was undertaken between the
project team and community leaders, as well as liaison
with village, district and provincial health staff. Village
health workers provided participants with information
regarding the surveys and signed informed consent was
documented at the time of enrolment for the surveys. The
survey team assisted the village health workers where par-
ticipants expressed concerns or uncertainty relating to any
aspect of their participation. The project was approved by
the Human Research Ethics Committee of the National
Institute of Malariology, Parasitology and Entomology
(Hanoi, Vietnam), the Walter and Eliza Hall Institute of
Medical Research (Melbourne, Australia) and Melbourne
Health (Melbourne, Australia).BMC Public Health 2009, 9:261 http://www.biomedcentral.com/1471-2458/9/261
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Results
Three hundred and eighty-two women participated in the
baseline survey, and 338 and 364 women attended the 3-
month and 12-month post-implementation surveys
respectively. Details of the study design and number of
women enrolled in each survey are shown in Figure 1, and
baseline demographic data are shown in Table 1. Alto-
gether, 349/382 women had Hb measured at baseline,
335/338 in the three month and 363/364 in the 12 month
survey. Figure 2 shows the Hb means and 95% confidence
intervals at each survey point. The prevalence of anemia at
baseline was 37.5% (131/349), (95% CI 31.3, 44.8), at
three months post-intervention 28.4% (94/335) (24%
reduction, RR 0.76, 95% CI 0.58, 0.98, p = 0.036) and
19.3% (70/363) at 12 months post-implementation, a
reduction on baseline prevalence of 49% (RR 0.51, 95%
CI 0.37, 0.71, p < 0.001). The prevalence of mild anemia
(Hb* <120 g/L & > = 100 g/L) and moderate/severe ane-
mia, (Hb<100 g/L) at baseline, three and 12 months post-
implementation is shown in Figure 3.
Geometric means for serum ferritin, soluble transferrin
receptor and the TfR/F-Index are shown in Table 2. The
serum ferritin geometric means and 95% CI are shown in
Figure 4, mapped to a log scale. The prevalence of iron
deficiency anemia at baseline was 14.0% (46/329) (95%
CI, 10.2, 17.7). Three months post-implementation it had
reduced to 5.9% (19/320) a reduction of 57% (RR 0.43,
95% CI 0.26, 0.70, p = 0.001) and at twelve months post-
intervention was 4.5% (16/353) or 78% less than baseline
(RR 0.32, 95% CI 0.15, 0.68, p = 0.003). Prevalence of
iron deficiency with or without anemia was 22.8% (75/
329) (95% CI 16.9, 28.6). By three months post-imple-
mentation this had reduced to 10.9% (35/320), a 52%
reduction in prevalence (RR 0.48, 95% CI 0.34, 0.69, p <
0.001) followed by a further small reduction to 59% of
baseline (RR 0.41, 0.26, 0.64, p < 0.001), a prevalence of
9.3% (33/353).
The prevalence of hookworm infection by severity at base-
line and at the 3- and 12-month post-implementation
surveys is shown in Table 3. Overall prevalence of hook-
worm infection at baseline was 76.2% (279/366). At the
three month post-implementation survey overall preva-
lence was 56.3% (126/224), a 26% reduction (RR 0.74,
95% CI 0.62, 0.89, p < 0.001) and at 12 months 23.0%
Flow diagram of evaluation of WIFS # and 4 monthly deworming program: baseline, 3- and 12-months post-implementation Figure 1
Flow diagram of evaluation of WIFS # and 4 monthly deworming program: baseline, 3- and 12-months post-
implementation. # WIFS = Weekly Iron-Folic acid Supplementation * WRA = Women of Reproductive Age defined as aged 
between 15 – 45 years.
Post-implementation 
surveys
August 2006 
338 WRA enrolled for 3-
month survey 
Compliance monitoring 
May 2006 
Implementation of WIFS and regular deworming program 
Tran Yen and Yen Binh districts (52,000 WRA) 
November 2005 
382 eligible WRA* enrolled for baseline survey 
July 2006 
253 WRA interviewed
April 2007 
364 WRA enrolled for 
12-month survey BMC Public Health 2009, 9:261 http://www.biomedcentral.com/1471-2458/9/261
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representing a 70.0% reduction in prevalence (RR 0.30,
95% CI 0.24, 0.39, p < 0.001). The prevalence of any STH
infection was 83.5% (95% CI 77.6, 89.5) at baseline,
64.3% (95% CI 55.7, 72.8) at three months and 32.7
(95% CI 25.0, 38.4) at twelve months post-implementa-
tion. Risk ratios for the change in prevalence of any soil
transmitted infection at three- and twelve-months post-
implementation were 0.77 (95% CI, 0.66, 0.89, p <
0.001) and 0.38 (95% CI, 0.30, 0.47, p < 0.001) respec-
tively.
To assess compliance, the independent monitor inter-
viewed 253 women of whom 251 had received at least
some iron tablets. On a ten week recall, and supported by
counting remaining tablets in the women's homes, two
women reported not taking any iron tablets and 202/249
(71.1%) reported taking 6 or more tablets. High compli-
ance was associated with literacy and education levels,
73% (154/211) of literate women reported high compli-
ance compared with 50% (15/30) of illiterate women. For
the deworming compliance, 225/241 (93.4%) of non-
pregnant women received the albendazole and 217/225
(96.4%) of women receiving tablets reported taking it.
Discussion
We have successfully integrated a large-scale, universal
WIFS and deworming program into an existing public
health structure. The program was distributed free of
charge by village health workers to all women of repro-
ductive age in the study districts. The post-implementa-
tion surveys showed an ongoing reduction in the
prevalence and severity of anemia and hookworm infec-
tion over a twelve-month period. The independent moni-
tor's report on the effectiveness of the distribution system
and women's compliance supports the premise that the
WIFS and regular deworming program was the principle
reason for these improvements.
Table 1: Demographic characteristics of women participating in the baseline survey in November 2005.
Demographic Number of respondents Mean ± SD or frequency (%)
Age (years) 382 30.1 ± 7.9
Number of children 378 1.7 ± 1.1
Education finished 375
None/Primary (Grades 1–5) 84 (22.4)
Secondary (Grades 6–9) 211 (56.3)
High (Grades 10–12)/Post-secondary 80 (21.3)
Meat consumption (meals/week) 369 4.0 ± 2.9
Outdoor work (vs. indoor work) 372 317 (85.2)
Time since previous deworming 352
1 wk-12 months 50 (14.2)
1 year to <10 years 160 (45.5)
≥ 10 years/never 142 (40.3)
Mean hemoglobin (95% CI) at baseline, 3- and 12-months  post-implementation Figure 2
Mean hemoglobin (95% CI) at baseline, 3- and 12-
months post-implementation.
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The strength of our approach was that distribution was
easily integrated into existing health services and was
made freely available to all women, regardless of socioe-
conomic or marital status. This was accompanied by
nutritional education for communities and their health
workers. This meant that the benefits of iron sufficiency
were available for all women in their childbearing years,
and their enthusiasm for the program was shown by the
continued improvement in iron status and worm infec-
tion prevalence over twelve months, suggesting high com-
pliance. The program was viewed as practical and effective
by all levels of the health sector and the community and
has now been expanded to every district in Yen Bai prov-
ince.
The main limitation to the study was the absence of a con-
trol group. This would have allowed us to establish the
prevalence of anemia and iron deficiency based on the
proportion of women who responded to iron supplemen-
tation/deworming compared with those receiving pla-
cebo, and to be able to attribute response to the
intervention. However, the main objective of the study
was to conduct a large demonstration project using WIFS/
deworming as an established strategy for reducing anemia
and iron deficiency amongst women in developing coun-
tries, and we did not feel it ethical to include a control arm
in which women were not treated for anemia and STH
infections.
The residual anemia prevalence of 19.5% may be mainly
explained by causes of anemia other than iron deficiency,
such as genetic hemoglobinopathies, which are found
amongst certain populations in South East Asia [25,26]. It
has been estimated that in the WHO Western Pacific
Region less than four percent of the population carry a Hb
disorder [27] while a later study of schoolchildren in a dif-
ferent province of northern Vietnam found the prevalence
of hemoglobinopathy (reporting totaled figures for
HbA2, HbAE and HbF, others not tested for) to range
between 3.8 and 9.3% [28]. Malaria is unlikely to have
been a cause of anemia in the target population as it has
been largely eliminated from the province, with only two
imported cases reported in 2005 (Dr. L. B. Phu, Director
Malaria Control Program, Yen Bai, Personal Communica-
tion). Compliance monitoring suggested that noncompli-
ance was uncommon in the study group. However, to
maintain high compliance we developed new training,
educational and promotional materials for health workers
and women following the 3-month compliance survey, as
it showed that low and non-compliance with taking the
weekly iron/folic acid supplement was associated with
low education levels.
There have been few WIFS/multi-micronutrient programs
successfully maintained for 12 months or more and most
have targeted pregnant women [29,30] and/or adolescent
schoolgirls and small children [29,31]. A WHO-spon-
sored program in three South-east Asian countries pro-
vided free daily iron supplements for pregnant women
and encouraged non-pregnant women to purchase weekly
iron supplements [15]. Extensive social marketing was
undertaken within the targeted communities. In Vietnam,
mean Hb levels increased by 6.0 g/L in a cohort of non-
pregnant women tested four times over twelve months
[32]. In Cambodia increases in Hb levels were associated
with higher socio-economic status in groups of school-
girls, garment factory workers and rural women [33], and
in the Philippines there was a significant increase in serum
ferritin but minimal change in Hb [34]. Dwivedi et al
(2006) reported a Government-sponsored community-
Table 2: Comparisons of iron status markers at baseline and 3- and 12-months post-implementation.
Survey Serum ferritin μg/L* Soluble Transferrin Receptor mg/L* TfR/Fe-Index*
n Mean 95% CI n Mean 95% CI n Mean 95% CI
Baseline 329 28.2 (24.2, 32.9) 336 1.69 (1.60, 1.78) 326 1.24 (1.05, 1.14)
3 month 320 38.9 (34.4, 44.0) 329 1.71 (1.63, 1.80) 320 1.10 (1.01, 1.07)
12 month 353 43.2 (38.6, 48.0) 361 1.41 (1.34, 1.48) 352 0.95 (0.92, 0.98)
* Exponentiated means and 95%CIs of log transformed values, SE adjusted for clusters as village.
Geometric mean serum ferritin (95% CI) at baseline, 3- and  12-months post-implementation Figure 4
Geometric mean serum ferritin (95% CI) at baseline, 
3- and 12-months post-implementation.
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based WIFS program targeted at adolescent girls in 13
Indian states. A cross-sectional survey after 12 months
showed a reduction in anemia prevalence ranging from
5% to 50% and, in one of the Indian states, a 70% reduc-
tion after two years of supplementation.
Conclusion
In conclusion, our results show that free, universal WIFS
with regular deworming was associated with a reduced
prevalence and severity of anemia and hookworm infec-
tion in non-pregnant women over a 12-month period.
The equitable, universal nature of the program and the
endorsement and involvement of the health sector from
provincial to village level were major factors in its ongoing
success. Countries with high rates of anemia in women
should urgently consider WIFS and regular deworming as
interim measures until sustainable alternatives are imple-
mented and shown to be effective [35,36].
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